The Impact of Folic Acid in The Treatment of Major - Thalassemia
Not Applicable
- Conditions
- Beta Thalassemia.Thalassemia(anemia) (disease)- major D56.1
- Registration Number
- IRCT2016011425989N2
- Lead Sponsor
- Vice chancellor for research, Guilan University ofMedical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Inclusion Criteria: Patients over Two Years of Age with Thalassemia Major Blood Recipient who Received Folic Acid Supplements for at Least 6 Months
Exclusion Criteria
Under two Years; Pregnant Women; Lactating Women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum folic acid levels. Timepoint: Supplements before and one month after stopping it. Method of measurement: In terms of micrograms per liter and by chemiluminescence.;Serum homocysteine level. Timepoint: Supplements before and one month after stopping it. Method of measurement: In terms of micromoles per liter and by chemiluminescence.
- Secondary Outcome Measures
Name Time Method